Location History:
- Killingworth, CT (US) (1992)
- Edmonds, WA (US) (1998 - 1999)
- Doylestown, PA (US) (2002)
Company Filing History:
Years Active: 1992-2002
Title: The Innovative Contributions of Peter A Kiener
Introduction
Peter A Kiener is a notable inventor based in Edmonds, Washington. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic proteins. With a total of six patents to his name, Kiener's work has the potential to impact the treatment of various diseases.
Latest Patents
Kiener's latest patents include groundbreaking inventions such as DNA molecules encoding human CLAX proteins and their soluble fusion proteins. This invention provides isolated novel cDNA sequences encoding a human C-type lectin and three homologues, collectively referred to as "CLAX" (C-type Lectin, Activation Expressed) proteins. The invention also encompasses methods for utilizing these nucleic acid sequences, polypeptides, fusion proteins, and specific antibodies. The genes of CLAX are expressed in lymphoid tissues and activated T lymphocytes, offering potential utility in pharmaceutical compositions for preventing and treating infectious, inflammatory, and allergic diseases. Another significant patent involves the CTLA4 receptor, which is identified as a ligand for the B7 antigen. This invention includes the complete amino acid sequence encoding the human CTLA4 receptor gene and methods for expressing CTLA4 as an immunoglobulin fusion protein.
Career Highlights
Kiener is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and innovations. His work has been instrumental in developing therapies that target immune responses, showcasing his expertise in immunology and molecular biology.
Collaborations
Throughout his career, Kiener has collaborated with esteemed colleagues such as Peter S Linsley and Jeffrey A Ledbetter. These collaborations have further enriched his research and contributed to the advancement of therapeutic strategies in immunology.
Conclusion
Peter A Kiener stands out as a prominent inventor in the biotechnology field, with a focus on innovative solutions for immune-related diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.